Covered recipient · General Payments record
NESTOR DANTE VERANO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology
General Payments · PY2021–2024
$2,737.90
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,037.63 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $247.60 | 2 |
| Novo Nordisk AS | $169.76 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $149.61 | 4 |
| Outset Medical Inc | $136.21 | 1 |
| CorMedix Inc. | $124.50 | 1 |
| Ardelyx, Inc. | $106.33 | 1 |
| GlaxoSmithKline, LLC. | $103.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $122.61 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406528 | CMS |
| Amgen Inc. | $124.99 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117406530 | CMS |
| Ardelyx, Inc. | $106.33 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146749278 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $15.63 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141515817 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $21.43 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141517495 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $8.00 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141519395 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $104.55 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141523329 | CMS |
| CorMedix Inc. | $124.50 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082023226 | CMS |
| GlaxoSmithKline, LLC. | $103.62 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116465408 | CMS |
| Novo Nordisk Inc | $169.76 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100257872 | CMS |
| Outset Medical Inc | $136.21 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138611762 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.